# 5 - Critic Output

# CRITIQUE OF PREMIUM SUBSCRIPTION TIER LAUNCH MEMO

## CRITIQUES

1. **No baseline metrics provided to justify any option**. The memo claims $213 CLV uplift (15% from $1,420 baseline) but never validates the $1,420 baseline exists, what current repeat purchase rate is, or whether historical campaign data supports 15% lift assumptions. The entire financial case rests on unvalidated numbers that "must be confirmed" in Week 1—meaning we're choosing between options without knowing if the business case is real.

2. **Kill switch criteria are unenforceable without baseline data**. The memo triggers kill switches if "pilot cohort CLV underperforms control group by >5% at Week 8" but CLV cannot be measured in 8 weeks for a subscription business. CLV requires 12-24 month observation windows. The memo conflates early engagement metrics (purchase frequency, AOV) with actual lifetime value, rendering the primary financial kill switch meaningless.

3. **Gate structure creates illusion of rigor without decision authority**. The memo defines GO/NO-GO gates at Week 1 Day 3 (Gate 1) and Day 5 (Gate 2) but never specifies who has authority to call NO-GO or what happens if gates fail. If Finance reports negative unit economics at Gate 1, does the entire initiative stop? Does VP Product have unilateral veto power? The gate design allows momentum bias to override failed gates because there's no escalation process.

4. **"Hand-selected pilot cohort from engaged, high-satisfaction customers" destroys statistical validity**. The memo proposes cherry-picking satisfied customers to reduce brand risk, which guarantees selection bias and makes the control group comparison worthless. Results from a self-selected satisfied cohort cannot predict performance with general population, making the entire "pilot generates learning" premise false.

5. **The 4-week delay timeline is fantasy**. Week 1 requires Finance to deliver full margin structure (Day 3), Engineering to assess billing feasibility (Day 5), Operations to confirm shipping capacity (Day 5), Product to run customer survey n=200+ (Day 5), AND VP Product to analyze top 10 SKUs (Day 5). This assumes every function drops all other work to staff this analysis with zero coordination overhead. The memo provides no budget, no staffing plan, and no acknowledgment that these teams have existing roadmaps.

## MISSING_INFO

- **Current financial baseline**: What is actual blended margin %, current customer acquisition cost, current repeat purchase rate, and current CLV calculation methodology? Without this, we cannot determine if 15% uplift is meaningful or if unit economics will ever be positive.

- **Billing platform technical constraints**: What platform are we currently using? Does it support subscription billing at all, or does "feasibility assessment" mean a 6-month re-platforming project? The memo treats this as a Week 1 question but the answer determines if Option B is viable at all.

- **Customer base size and segmentation**: The memo assumes 50,000+ customers (making 5% = 2,500) but never confirms this. If customer base is 10,000, a 5% pilot is 500 customers—likely underpowered for statistical significance even with extended timeline.

- **Definition of "Q3" and seasonal relevance**: The memo references Q3 timing and "seasonal window" but never states what fiscal calendar we're using, what month Q3 ends, or why Q3 specifically matters. A "4-week delay" that pushes launch from September 25 to October 23 has very different implications than June 25 to July 23.

- **Investment budget and resource allocation**: How much will the 2-week data sprint cost in employee time? What is the billing integration budget? What is acceptable pilot investment ceiling before ROI becomes impossible? The memo says "Finance confirms investment fits existing budget" but never states what that budget is.

- **Competitive intelligence**: The memo lists "competitor subscription programs" as an unknown but provides zero information on whether competitors already offer subscriptions, what they charge, or what features they include. This determines whether we're first-mover or late-follower.

- **Legal and compliance review timeline**: Subscription terms require legal review, payment processing may require PCI-DSS compliance validation, and auto-renewal regulations vary by state/country. None of this appears in the timeline.

## HALLUCINATION_RISKS

- **"$213 CLV uplift achievable through subscription benefits alone"**: No supporting analysis provided. This number may come from a different business context, aspirational modeling, or misinterpretation of another metric entirely.

- **"Top 2 SKUs represent >40% of revenue"**: Stated as assumption but treated as fact when designing pilot. If this is wrong, entire SKU selection strategy collapses.

- **"5% cohort" provides sufficient statistical power**: Analytics is tasked to "calculate minimum detectable effect size in Week 1" but the memo already commits to 5% in the recommendation. This is circular logic—we've chosen the cohort size before validating it's adequate.

- **"4-week delay still captures Q3 seasonal timing"**: We don't know what Q3 represents, when it ends, or whether "Q3+1 month" means we've already missed the seasonal window entirely.

- **"Matched control group design" is feasible**: Creating truly matched controls requires sophisticated propensity score modeling or randomization. The memo assumes this is trivial but provides no evidence the analytics team has this capability or that customer data supports matching methodology.

- **Kill switch can be implemented "without irreversible customer relationship damage"**: This is asserted but never validated. Canceling a subscription program mid-flight, even with refunds, may create lasting brand damage that exceeds initial pilot risk.

## ESCALATE

**Yes—escalate to executive leadership before proceeding.**

**Reasons:**

1. **Financial viability unvalidated**: The entire business case rests on $213 CLV uplift that has no supporting analysis. Proceeding to detailed planning before confirming baseline economics risks wasting 4 weeks of cross-functional effort on a fundamentally unprofitable initiative.

2. **Resource commitment undefined**: The memo requires Finance, Engineering, Operations, Product, Analytics, and Legal to dedicate significant effort over 4 weeks with no staffing plan, budget allocation, or trade-off discussion against existing priorities. This level of resource reallocation requires executive approval and roadmap adjustment across multiple functions.

3. **Statistical validity compromised by design**: The hand-selected pilot cohort approach and 8-week CLV measurement timeline guarantee the pilot will produce misleading results, potentially driving a catastrophic scale-up decision based on false positives. Executive leadership must approve accepting compromised learning quality in exchange for speed.

4. **No gate enforcement mechanism**: The GO/NO-GO gates lack decision authority and escalation paths. If Gate 1 reveals negative unit economics, there's no defined process to kill the initiative, creating risk that sunk cost fallacy drives continued investment in a doomed project.

## WHAT_WOULD_CHANGE_MY_MIND

- **Validated baseline financials showing current state supports case**: If Finance provides analysis showing current CLV = $1,420, current margin structure = 35%+, and historical upsell campaigns have achieved 10-15% CLV lifts with similar mechanics, the financial case becomes credible.

- **Engineering confirms subscription billing feasible in 4-week timeline**: If Engineering provides written confirmation that current platform supports recurring billing with <2 weeks integration effort and has already implemented kill switch capability in other contexts, the technical risk drops substantially.

- **Analytics demonstrates sufficient statistical power with proposed design**: If Analytics shows calculation that 5% cohort (with confirmed customer base size) provides 80%+ power to detect 15% CLV lift within 8 weeks using leading indicators (purchase frequency, AOV) that historically correlate r>0.85 with 12-month CLV, the measurement concern is addressed.

- **Clear gate decision authority and NO-GO consequences defined**: If the memo specifies "CFO has unilateral authority to call NO-GO at Gate 1; failed gate triggers immediate project suspension and executive review before any restart" with explicit escalation to CEO, the governance risk is mitigated.

- **Random assignment pilot design instead of hand-selected cohort**: If the memo commits to random assignment from eligible high-value segment (not cherry-picked satisfied customers) and includes plan to manage brand risk through enhanced support staffing and communication, the statistical validity is preserved while controlling operational risk.

- **Competitive analysis shows clear white space or differentiation**: If Product provides evidence that zero competitors offer subscription models in our category OR our proposed benefits are materially differentiated (not just "me-too" discounts + shipping), the strategic rationale strengthens.
